CME Group Inc. (CME) stock
CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 10/3020% above fair value
$319.37+1.40 (+0.44%)
Close on Nov 16, 2026Market cap $114.31BP/E 26.2Yield 1.57%
CME r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for CME
CME has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?